alexa Fungal Spondylodiscitis: Unexpected Diagnosis, Case Rep
ISSN: 2165-7939

Journal of Spine
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Case Report

Fungal Spondylodiscitis: Unexpected Diagnosis, Case Report and Literature Review

Alqroom Y. Rami1*, Michalitsis G. Sotirios2, Leue Lukas2, Hunger Frank3 and Franke Jorg3

1Department of Neurosurgery, Royal Medical Services, King Hussein Medical Centre, Amman, Jordan

2Spine Center, Hospital Klinikum Dortmund, Dortmund, Germany

3Institute for Hospital Hygiene and Clinical Microbiology, Hospital Klinikum Dortmund, Dortmund, Germany

*Corresponding Author:
Rami Alqroom, MD
Spine surgeon, Department of Neurosurgery
Royal Medical Services
King Hussein Medical Center, Amman, Jordan
Tel: 00962797017870
Fax: 004923195321020
E-mail: [email protected]

Received date: June 03, 2016; Accepted date: June 20, 2016; Published date: June 22, 2016

Citation: Rami AY, Sotirios MG, Lukas L, Frank H, Jorg F (2016) Fungal Spondylodiscitis: Unexpected Diagnosis, Case Report and Literature Review. J Spine 5:313. doi:10.4172/2165-7939.1000313

Copyright: © 2016 Rami AY, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

Study design: Case report of a rare case of spondylodiscitis due to Candida species (C. tropicalis).

Objective: To report our case with this rare condition (Fungal spondylodiscitis due to Candida tropicalis) in a 75- year old female immune-competent patient presenting with low back pain and literature review.

Summary of background data: Spondylodiscitis or discitis is an infection in the intervertebral disc space and adjacent end plates, this disease accounts for 2–7% of all cases of pyogenic osteomyelitis, which affects different age groups. There is a wide spectrum of causative agents: pyogenic, granulomatous or parasitic. Nowadays incidence has increased the rise in the prevalence of immunosuppressed patients and intravenous drug abusers, and the increase in spinal surgeries. Nonetheless, the microbiological diagnosis of infectious spondylodiscitis is often difficult to establish and the disease requires prolonged antibiotic treatment in combination with surgical intervention are the cornerstone of management. Candida spondylodiscitis usually affects immunocompromised patients after haematogenous dissemination.

Methods: A 75-year-old female patient, who developed low back pain, pain radiated intermittently to both lower limbs, not associated with any sensorimotor deficit. Imaging of the thoraco-lumbosacral spine at the same day (X-ray, CT and MRI) showed alteration of the inter-vertebral disc in Th11/12 and L1/L2. The patient was treated surgically under general anaesthesia and fluoroscopy control. Results: We successfully treated this patient with spondylodiscitis due to fungal infection. By surgical debridement, fusion and pharmaceutical agents: amphotericin and/or fluconazole. Thoraco-lumbosacral CT, 12 weeks after surgery showed decreased oedema of the vertebra, disc space and pre-spinal soft tissues, the patient was symptom less.

Conclusion: Candidal spondylodiscitis is a rare fungal infection should be suspected in immunocompromised patients and elderly with chronic diseases. Without treatment, the disease is progressive and leads to vertebral destruction and spinal cord and neural Preservation of the structure and function of the spine and pain alleviation. Established pharmaceutical agents are amphotericin and/or fluconazole for a minimum of 3 months and surgical debridement of the disc with instrumented fusion is highly recommended.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords